Summit Therapeutics, Inc. (SMMT)
17.54
+0.05
(+0.29%)
USD |
NASDAQ |
Jan 02, 16:00
17.54
0.00 (0.00%)
After-Hours: 17:16
Summit Therapeutics Market Cap: 13.06B for Jan. 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 13.49B |
| Alnylam Pharmaceuticals, Inc. | 52.83B |
| Arrowhead Pharmaceuticals, Inc. | 9.201B |
| Insmed, Inc. | 37.78B |
| CorMedix, Inc. | 958.47M |
Market Cap Related Metrics
| PEG Ratio | -0.0405 |
| Price to Book Value | 67.92 |
| Price | 17.54 |
| Earnings Yield | -7.08% |
| PEGY Ratio | -0.0405 |